Back to CVE records
Medium 4.2Published Aug 18, 2026

CVE-2026-75833Grav API Plugin Open Redirect via Backslash Bypass

Updated under an hour ago ()

Does this affect you?

It affects getgrav grav. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

The Grav API plugin (getgrav/grav-plugin-api, bundled with Grav 2.0's admin-next/API stack) before version 1.0.14 contains an open redirect weakness in SsoController::sanitizeReturnTo(). The function rejects a literal '//' prefix but does not account for browsers normalizing backslashes to slashes in special (http/https) schemes, so a returnTo value such as '/\evil.com' passes the guard and is later resolved by the browser as the protocol-relative URL '//evil.com'. Following a legitimate OAuth login flow, an attacker-supplied returnTo parameter could redirect an authenticated victim to an attacker-controlled site for post-login phishing. Full browser-side exploitability depends on the admin-next SPA's client-side oauth-callback handler and was not independently verified by the reporter.

CVSS
4.2 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:L/I:L/A:N
Weakness (CWE)
CWE-601
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulnCheck
NVD analysis
Deferred
Record last updated
Aug 18, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
getgrav grav
getgrav:grav (from the name)
before 1.0.14; 1.0.14 not affected
CNA record

References

  • vendor-advisory
  • third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.